360 findings · Molecular
- MolecularStrong
Tirzepatide improves β-cell function in T2D patients by reprogramming stressed β cells and restoring β-cell identity through FOXO1-dependent transcriptional reactivation.
Practitioners may consider tirzepatide as a therapeutic option for improving β-cell function in T2D patients.
Supports 2026New - MolecularStrong
Emerging therapeutic approaches aim to engage multiple bioenergetic pathways to restore metabolic equilibrium.
Practitioners should consider multi-target approaches in developing treatments for metabolic dysfunction.
Supports 2026New - MolecularStrong
Bariatric surgery reduces the risk for overall cancer incidence, particularly female cancers.
Bariatric surgery may lower cancer risk, especially in women.
Supports 2015 - MolecularStrong
Bariatric surgery increases the risk for alcohol use disorders, particularly in gastric bypass operated patients.
Patients should be monitored for alcohol use disorders after bariatric surgery.
Supports 2015 - MolecularStrong
ALOXE3 is activated during fasting and enhances insulin sensitivity via hepatic PPARγ.
Targeting ALOXE3 may be a viable strategy for improving insulin sensitivity in metabolic diseases.
Supports 2018 - MolecularStrong
Variation at the leptin receptor gene (LEPR) is associated with obesity in humans.
Practitioners should consider genetic factors related to the leptin receptor when addressing obesity.
Supports 1997 - MolecularStrong
Ubiquitin-protein conjugates were elevated at 2 days of immobilization (12%, p < 0.05) but were not different from baseline at 14 days.
Early increases in protein ubiquitination may indicate initial muscle stress, but this does not persist.
Supports 2010 - MolecularStrong
Insulin decreases the expression of genes involved in oxidative metabolism in healthy muscle through reduced FoxO1 phosphorylation and nuclear exclusion.
This finding highlights the importance of insulin in regulating oxidative metabolism in healthy individuals.
Supports 2005 - MolecularStrong
Insulin resistance (IR) is a cardinal feature of type 2 diabetes mellitus (T2DM) and contributes to elevated cardiovascular disease (CVD) risk.
Addressing insulin resistance is crucial in managing T2DM and reducing CVD risk.
Supports 2017 - MolecularStrong
Dietary fatty acids interact with genetic variants to modify circulating omega-3 fatty acids.
Practitioners should consider genetic factors when assessing dietary fatty acid impacts.
Supports 2015 - MolecularStrong
Compartment-specific interactions exist between genetic variants and dietary fatty acids.
Measurement methods should be tailored to improve understanding of gene-diet interactions.
Supports 2015 - MolecularStrong
Pharmacological interventions may attenuate the metabolic and inflammatory changes seen in EAT.
These pharmacological options may be considered in managing EAT-related cardiac dysfunction.
Supports 2021 - MolecularStrong
The gut microbiome may contribute to the development of obesity in humans.
Practitioners should consider the gut microbiome as a potential factor in obesity management.
Supports 2023 - MolecularStrong
The decision tree yields an AUC of 0.898 for phenotyping PCOS.
Clinicians can utilize this decision tree for effective phenotyping of PCOS.
Supports 2022 - MolecularStrong
The decision tree aims to improve PCOS management by reducing multiple blood tests and physician workload.
This decision tree could streamline the diagnostic process for PCOS, making it more efficient for healthcare providers.
Supports 2022 - MolecularStrong
Consumption of cherries may help to attenuate pain and decrease blood concentrations of biomarkers linked to skeletal muscle degradation.
Incorporating cherries into the diet may benefit individuals looking to reduce muscle degradation and pain.
Supports 2020 - MolecularStrong
Cherry anthocyanins may represent a potential non-pharmacological remedy for cardiometabolic diseases.
Cherries may be recommended as a dietary addition for managing cardiometabolic health.
Supports 2020 - MolecularStrong
CE/BZA increased serum high-density lipoprotein (HDL)-cholesterol and serum markers of hepatic de novo lipogenesis.
CE/BZA may improve HDL cholesterol levels and influence fat metabolism.
Supports 2020 - MolecularStrong
Yoga significantly improved the expression of OGG1 protein, indicating enhanced DNA repair in T2D subjects (17.55; P = .034).
Yoga may enhance DNA repair mechanisms in individuals with type 2 diabetes.
Supports 2021 - MolecularStrong
The beneficial effect of yoga on DNA damage in T2D subjects is mediated by the mitigation of oxidative DNA damage and enhancement of DNA repair.
Yoga's benefits for DNA damage in type 2 diabetes are linked to its effects on oxidative stress and DNA repair.
Supports 2021 - MolecularStrong
The amino acid profile of bread with 5% WSF is higher than that of the control bread.
Using WSF can enhance the amino acid content of bread, beneficial for nutrition.
Supports 2023 - MolecularStrong
The post-ACCORD era represents a significant shift in the landscape of cardiovascular outcomes trials (CVOTs) in type 2 diabetes mellitus (T2DM), emphasizing the safety of glucose-lowering agents.
Practitioners should prioritize the safety profiles of glucose-lowering agents in T2DM management.
Supports 2016 - MolecularStrong
Conventional antihyperglycemic medications have minimal effect on lowering cardiovascular risk in T2DM patients.
Practitioners should be aware that conventional medications may not effectively reduce cardiovascular risk in T2DM patients.
Supports 2018 - MolecularStrong
Higher concentration of nicotinamide phosphoribosyltransferase (NAMPT) protein is associated with faster phosphocreatine (PCr) resynthesis.
Increasing NAMPT levels may enhance muscle recovery rates post-exercise.
Supports 2020